2.1.1. Non-Randomized, Non-Concurrent, and Unblinded
RECRUITMENT
The non-randomized design of the ADLIFE clinical trial lies on the recruitment process, as detailed in The control group will be retrospectively selected to guarantee that the control group receives usual care. The study will be unblinded, since all stakeholders involved in the intervention group will use the ADLIFE toolbox and will thus be aware of the intervention However, since data will be retrospectively collected from the electronic health records (EHR) for the control and the intervention group, no information bias is expected in the data collection process. The study design and the data collection flow are shown in 